Please login to the form below

biologic

This page shows the latest biologic news and features for those working in and with pharma, biotech and healthcare.

Roche’s MabThera beats incumbent drug in pemphigus vulgaris phase 3

March. The approvals made MabThera the first biologic approved for use in moderate to severe cases of the rare autoimmune skin disease and in Roche’s words, ‘the first major advancement

Latest news

FDA approves Bavarian Nordic’s smallpox and monkeypox vaccine

FDA’s Center for Biologics Evaluation and Research.
Abeona Therapeutics’ rare disease phase 3 trial halted due to FDA concerns

support a future Biologics License Application,” he added.
Novartis eyes potential new indication for Cosentyx

However, the inflammatory and immunology field is also becoming increasingly competitive thanks to a new class of biologic therapies which are competing for market share.
J&J's Tremfya filed for approval in US for psoriatic arthritis

DISCOVER-1 studied Tremfya in 381 participants, including some who were previously treated with anti-TNF biologics, and the duration of the study was 52 weeks. ... DISCOVER-2 included 739 biologic-naive participants, and continued up to 100 weeks.
Novartis expands its generics franchise with natalizumab biosimilar

Says affordability is a challenge to access. Sandoz, Novartis’ generics unit, has agreed to license a biosimilar of Biogen’s Tysabri for multiple sclerosis from Polpharma Biologics. .

More from news
Approximately 18 fully matching, plus 554 partially matching documents found.

Latest Intelligence

A snapshot of Crescendo Biologics

The company is based in Cambridge, UK, which is renowned for its antibody and biologics research and expertise, making it a prime location for Crescendo’s work. ... Cambridge, UK is probably the leading antibody and biologics development location in
The Golden Goose

Ten years ago, around the time the Affordable Care Act, ie, Obamacare, became law, Congress passed the Biologics Price Competition and Innovation (BPCI) Act, hoping it would do for biologics what ... And they tend to be priced closely to their competitors
Encouraging signs in biomarker R&D

B-MS withdrew its supplemental Biologics License Application (sBLA) in January this year, explaining that ‘further evidence on the relationship between TMB and PD-L1 is required to fully evaluate the
25 Women Leaders in UK Healthcare

That’s why Theodora Hall taking on the top job at emerging UK biotech Crescendo Biologics is worth noting, as she represents a new generation of leaders in the sector.
Transitions in healthcare

Switching from an originator biologic to a cheaper biosimilar. These are all examples of the kind of treatment transitions patients experience that can be supported by Patient Support Programmes.

More from intelligence
Approximately 4 fully matching, plus 77 partially matching documents found.

Latest appointments

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

Bahija has more than 25 years of international leadership experience within the pharmaceutical industry, and joins Immunocore from AstraZeneca, where she has served as President of MedImmune, its global biologics research ... A champion for science and
BMS appoints new commercial leader, Davies joins Eisai and more

Commenting on her appointment, Schuermans said: “Sobi has unique capabilities, a heritage in biologics manufacturing, development and supply, and a very exciting future within the rare disease space.
Industry appointments

Most recently, Hassan built the oncology-focused biology, preclinical and biomarker units for Immunocore, overseeing early development and the first-in-human trial of a TCR based biologic targeting a melanoma
Nabriva Therapeutics appoints chief medical officer

medical affairs for small molecules and biologics.
Ipsen appoints Aidan Murphy as EVP, technical operations

He is promoted from senior VP biologics development and manufacturing. Ipsen has added to its executive leadership team in the form of Aidan Murphy, who becomes the biopharma’s executive vice ... being senior vice president biologics development and

More from appointments
Approximately 7 fully matching, plus 46 partially matching documents found.

Latest from PMHub

Innovative pricing and contracting options

3. For new entrants in the biologics space, adopting net pricing options is crucial since some US payers are volume sensitive and may prefer an older competitor drug that is clinically
MIT reveals new pill to deliver insulin

Alex:This device enables the delivery of all biologic drugs, not just insulin. ... For example, I confirmed the insulin was still active when pressed into the device and ensured the properties didn’t change considering that we are submitting the
Infographic: Rheumatoid arthritis (RA)

An overview of the RA biologic patient. Our RA market snapshot offers an introduction to the real world patient data collected by our Therapy Watch RA study.
Parachuting Behind Enemy Lines: OncoSec’s Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)

It is easy to perform and is more rapid than traditional chemical or biologic cell transfection techniques. ... does not negatively alter the biologic structure or function of the target cells.
News: Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)

A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter.